» Articles » PMID: 1361141

Toxicokinetics of Colchicine in Humans: Analysis of Tissue, Plasma and Urine Data in Ten Cases

Overview
Journal Hum Exp Toxicol
Publisher Sage Publications
Specialty Toxicology
Date 1992 Nov 1
PMID 1361141
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

1. A specific and sensitive radioimmunoassay was used to study the toxicokinetics of colchicine in seven cases of acute human poisoning. Post-mortem tissue concentrations of colchicine were measured in three further cases. Depending on the time of patient admission, two disposition processes could be observed. The first, in three patients, admitted early, showed a bi-exponential plasma colchicine decrease, with distribution half-lives of 30, 45 and 90 min. The second, in four patients, admitted late, showed a mono-exponential decrease. Plasma terminal half-lives ranged from 10.6 to 31.7 h for both groups. 2. Pharmacokinetic analysis of urine colchicine data was performed for two patients. The fraction of unchanged colchicine excreted in urine was about 30%, renal clearance was about 13 l h-1 and three-fold less than total body clearance (39 l h-1). The apparent volume of distribution was 21 l kg-1. 3. Post-mortem tissue analysis showed an ubiquitous colchicine distribution. Colchicine accumulated at high concentrations in the bone marrow (more than 600 ng g-1), testicle (400 ng g-1), spleen (250 ng g-1), kidney (200 ng g-1), lung (200 ng g-1) and heart (95 ng g-1); it was also found in the brain (125 ng g-1). 4. This toxicokinetic study shows that after massive ingestion, the disposition parameters and kinetics of colchicine are not markedly modified from those occurring in healthy volunteers. The absorption process was not delayed and the distribution and elimination half-lives were in the range known to occur with therapeutic doses.

Citing Articles

Efficacy of Colchicine for Prevention of Stroke and Adverse Cardiovascular Events: A Meta-analysis of 16 Randomized Controlled Trials.

Jaiswal V, Deb N, Hanif M, Wajid Z, Nasir Y, Naz S Am J Cardiovasc Drugs. 2024; 25(1):83-93.

PMID: 39460903 DOI: 10.1007/s40256-024-00689-7.


Progress in the management of acute colchicine poisoning in adults.

Wu J, Liu Z Intern Emerg Med. 2022; 17(7):2069-2081.

PMID: 36028733 PMC: 9417090. DOI: 10.1007/s11739-022-03079-6.


Unusual drug reaction with features of colchicine toxicity in a patient on colchicine and allopurinol.

Salari B, Joseph M, Eshaq M, Lowe L, Fullen D J Cutan Pathol. 2022; 49(11):938-942.

PMID: 35734802 PMC: 9796373. DOI: 10.1111/cup.14280.


A Hypothesis Regarding Neurosecretory Inhibition of Stress Mediators by Colchicine in Preventing Stress-Induced Familial Mediterranean Fever Attacks.

Korkmaz C, Cansu D, Cansu G Front Immunol. 2022; 13:834769.

PMID: 35251026 PMC: 8891608. DOI: 10.3389/fimmu.2022.834769.


Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review.

Zhang F, He Q, Qin C, Little P, Weng J, Xu S Acta Pharmacol Sin. 2022; 43(9):2173-2190.

PMID: 35046517 PMC: 8767044. DOI: 10.1038/s41401-021-00835-w.